Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2025International Journal of PharmaceuticsOpen Access

Revolutionizing age-related macular degeneration treatment: Advances and future directions in non-invasive retinal drug delivery systems

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAmit Kumar SahuAPAshmi R. PatelKSKiran H. Shetty

Discussion

Loading...

Member takes

Overview

This review highlights advancements in retinal drug delivery systems, suggesting new methods to improve bioavailability in AMD treatment.

Key Points

  • Age-related macular degeneration is a primary cause of vision loss and requires innovative treatment solutions.
  • Current anti-VEGF therapies depend on invasive injections, which can lead to complications like infections and poor compliance.
  • Emerging technologies, such as microneedle arrays and drug-eluting contact lenses, show potential for improved ocular drug delivery.
  • Personalized and stimuli-responsive delivery systems are essential for bridging laboratory innovations with clinical applications.

Cite This Study

Sahu et al. (2025) studied this question.

synapsesocial.com/papers/689a0c65e6551bb0af8cf965https://doi.org/10.1016/j.ijpharm.2025.126009
View Full Paper
Ask AI
Bookmark
Share